A Phase 1 Open-Label, Two-Arm, Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors

Trial Profile

A Phase 1 Open-Label, Two-Arm, Drug-Drug Interaction Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors

Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 May 2017

At a glance

  • Drugs Talazoparib (Primary) ; Itraconazole; Rifampicin
  • Indications Adenocarcinoma; Breast cancer; Cervical cancer; Ovarian cancer; Small cell lung cancer; Solid tumours
  • Focus Pharmacokinetics
  • Sponsors Medivation
  • Most Recent Events

    • 15 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top